CD8A and neoplasm: Oral supplementation of Bifidobacterium alone was shown to improve tumor control to the same magnitude as anti-PD-(L)1 therapy, and achieved in combined therapy combination a marked reduction of cancer outgrowth due to an increase in dendritic cell activity together with an enhanced response of CD8 + T cell within the tumor microenvironment.